Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Paricalcitol versus placebo on low- or high-sodium diet in type 2 diabetes with albuminuria
2011-001713-14Phase 2Completed
- Sponsor
- Mario Negri Institute for Pharmacological Research
- Start
- Mar 2012
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of paricalcitol in type 2 diabetes mellitus (T2DM) (2 arms), sponsored by Mario Negri Institute for Pharmacological Research. Primary endpoint: Change in urinary albumin excretion rate. Started Mar 2012; status: completed.
02
Drugs
paricalcitol
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on 2011-001713-14.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-001713-14.